Evidence map›Paper›PMID 28277931›Full record

ReviewRNA biology2017

Antibodies specific for nucleic acid modifications.

Regina Feederle, Aloys Schepers

Open access · bronzeAbstract readReview
In one paragraph

Review in RNA biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. No evidence for DNAScience advances · 2020
    Article
  12. Review
  13. Article
  14. Mapping and editing of nucleic acid modifications.Computational and structural biotechnology journal · 2020
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Regina Feederlea Monoclonal Antibody Core Facility and Research Group, Institute for Diabetes and Obesity , Helmholtz Zentrum München, German Research Center for Environmental Health GmbH , München , Germany.ORCID 0000-0002-3981-367X
Aloys Schepersa Monoclonal Antibody Core Facility and Research Group, Institute for Diabetes and Obesity , Helmholtz Zentrum München, German Research Center for Environmental Health GmbH , München , Germany.ORCID 0000-0002-5442-5608
Helmholtz Zentrum München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nucleotide modifications constitute marks in RNA and DNA that contribute to gene regulation, development and other cellular processes. The understanding of their intricate molecular roles has been hampered by the high number of different modifications, the lack of effective methods and tools for their detection and quantification as well as by their complex structure-function relationship. The recent development of RNA and DNA immunoprecipitation followed by high-throughput sequencing (RIP- and DIP-seq) initiated detailed transcriptome- and genome-wide studies. Both techniques depend on highly specific and sensitive antibodies to specifically enrich the targeted modified nucleotides without background or potential biases. Here, we review the challenges and developments when generating and validating antibodies targeting modified nucleotides. We discuss antibody-antigen interactions, different strategies of antigen generation and compare different binder formats suitable for state-of-the-art high resolution mapping and imaging technologies.

Indexed as

AnimalsAntibodiesAntibody SpecificityAntigensCarrier ProteinsEpigenesis, GeneticHumansNucleic AcidsProtein BindingReproducibility of ResultsAntibodiesAntigensCarrier ProteinsNucleic AcidsAntibodyepigenomicsepitranscriptomicsmodified nucleotidenucleic acid modification

Identifiers

PMID28277931
PMCPMC5699546
OpenAlexW2590232874

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.